Repositorio Dspace

Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppression

Mostrar el registro sencillo del ítem

dc.contributor.author Aldamiz-Echevarria, Teresa
dc.contributor.author Tejerina, Francisco
dc.contributor.author Fanciulli, Chiara
dc.contributor.author Díez, Cristina
dc.contributor.author Pérez, Leire
dc.contributor.author Bellon, José-María
dc.contributor.author Espinosa, Nuria
dc.contributor.author Guillen, Santiago-Moreno
dc.contributor.author del-Mar-Arcos-Rueda, María
dc.contributor.author Montero-Alonso, Marta
dc.contributor.author García-Fraile, Lucio
dc.contributor.author Asensi, Victor
dc.contributor.author Fernández-López, Marian
dc.contributor.author Corona-Mata, Diana
dc.contributor.author Cabello-Ubeda, Alfonso
dc.contributor.author Manso, Meritxell-Gavalda
dc.contributor.author Iribarren, José-Antonio
dc.contributor.author Pérez-Martínez, Laura
dc.contributor.author Valls, María-Remedios-Aleman
dc.contributor.author Portilla-Tamarit, Irene
dc.contributor.author Peraire, Joaquim
dc.contributor.author Suarez-García, Ines
dc.contributor.author Masia, Mar
dc.contributor.author Núñez-Orantos, María-José
dc.contributor.author Gutiérrrez-Liarte, Ángela
dc.contributor.author Imaz, Arkaitz
dc.contributor.author Hernández-Gutierrez, Cristina
dc.contributor.author Pitarch, María-Tasias
dc.contributor.author Rava, Marta
dc.date.accessioned 2026-11-18T11:23:19Z
dc.date.available 2026-11-18T11:23:19Z
dc.date.issued 2026-08
dc.identifier.citation Aldámiz-Echevarria T, Tejerina F, Fanciulli C, Diez C, Perez L, Bellón JM, et al. Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppression. HIV Medicine. agosto de 2026;27(8):1312-32. doi:10.1111
dc.identifier.issn 1464-2662
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/29299
dc.description.abstract OBJECTIVES: Lymphomas remain among the most frequent HIV-associated malignancies, with risk persisting despite effective virological control. This study describes the clinical, epidemiological and prognostic characteristics of lymphomas (both Hodgkin [HL] and non-Hodgkin [NHL]) in people living with HIV (PLWH), according to virological suppression at diagnosis and assesses lymphoma-related mortality at 1 year and overall survival at 5 years. METHODS: We conducted a multicentre retrospective study including PLWH from the Spanish CoRIS cohort, who were diagnosed with lymphoma between 2004 and 2022 and had HIV viral load data at diagnosis. Virological suppression was defined as HIV-1 RNA <100 copies/mL within the 6 months prior to and 1 month following lymphoma diagnosis. RESULTS: Among 18 573 PLWH included in CoRIS, 291 developed lymphoma, with virological data available for 245 individuals, of whom 49 (20%) had virological suppression. People with detectable HIV viral load had lower CD4 counts (median 180 cells/mm(3) [IQR 80-330] vs. 371 cells/mm(3) [IQR 202-583], p < 0.001) and more advanced Ann Arbor stage (stage III-IV: 82.0% vs. 64.1%, p = 0.027) compared with those with virological suppression. Despite this, they showed similar treatment response (complete remission: 67.1% vs. 76.2%) and relapse rates (16.3% vs. 18.4%, p = 0.779). Furthermore, virological suppression was not independently associated with 1-year lymphoma-specific or 5-year overall survival. CONCLUSIONS: In PLWH diagnosed with lymphoma, prognosis is independent of HIV virological status at diagnosis. These findings support that lymphoma management in PLWH should be guided by standard oncological criteria, alongside antiretroviral therapy, regardless of HIV viral suppression status.
dc.language.iso eng
dc.publisher WILEY
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es *
dc.subject.mesh Adult
dc.subject.mesh Female
dc.subject.mesh Humans
dc.subject.mesh Male
dc.subject.mesh Middle Aged
dc.subject.mesh CD4 Lymphocyte Count
dc.subject.mesh HIV Infections/drug therapy/complications/virology
dc.subject.mesh Hodgkin Disease/epidemiology/mortality
dc.subject.mesh Lymphoma, AIDS-Related/epidemiology
dc.subject.mesh Lymphoma, Non-Hodgkin/epidemiology/mortality
dc.subject.mesh Prognosis
dc.subject.mesh Retrospective Studies
dc.subject.mesh Spain/epidemiology
dc.subject.mesh Viral Load
dc.title Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppression
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 42144866
dc.relation.publisherversion https://onlinelibrary.wiley.com/doi/10.1111/hiv.70257
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1111/hiv.70257
dc.journal.title HIV MEDICINE
dc.identifier.essn 1468-1293


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta